thyroxine has been researched along with Alactasia in 8 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The preferred treatment for hypothyroidism is oral levothyroxine (LT4) ingestion, in doses that ensure a sustained state of hormonal balance." | 8.88 | The influence of lactose intolerance and other gastro-intestinal tract disorders on L-thyroxine absorption. ( Ruchała, M; Szczepanek-Parulska, E; Zybek, A, 2012) |
| "We describe a case of a 38-year-old woman who, after radioactive iodine therapy for Graves' disease, developed severe hypothyroidism despite receiving a high dose of levothyroxine (L-T4) tablet as replacement therapy." | 8.12 | Switching from the tablet to the powder formulation of levothyroxine corrects severe hypothyroidism in a patient with lactose intolerance. ( Aso, Y; Iijima, T; Jojima, T; Kogai, T; Ohira, E; Sakurai, S; Shinzawa, T; Tomaru, T; Usui, I, 2022) |
| "Purpose: to determine lactose intolerance (LI) prevalence in women with Hashimoto’s thyroiditis (HT) and assess the impact of LI on LT4 replacement dose." | 8.12 | Prevalence of Lactose Intolerance in Patients with Hashimoto Thyroiditis and Impact on LT4 Replacement Dose. ( Albertelli, M; Bagnasco, M; Bodini, G; Ferone, D; Furnari, M; Giannini, EG; Giusti, M; Marabotto, E; Navarro Rojas, FA; Savarino, E; Savarino, V; Sheijani, AD; Vera, L; Zentilin, P; Ziola, S, 2022) |
| " However, an abnormality in the bioavailability of LT(4) should also be considered in patients requiring large doses of LT(4) to achieve euthyroidism." | 5.33 | Lactose intolerance revealed by severe resistance to treatment with levothyroxine. ( Alonso, G; Muñoz-Torres, M; Varsavsky, M, 2006) |
| "The preferred treatment for hypothyroidism is oral levothyroxine (LT4) ingestion, in doses that ensure a sustained state of hormonal balance." | 4.88 | The influence of lactose intolerance and other gastro-intestinal tract disorders on L-thyroxine absorption. ( Ruchała, M; Szczepanek-Parulska, E; Zybek, A, 2012) |
| "We describe a case of a 38-year-old woman who, after radioactive iodine therapy for Graves' disease, developed severe hypothyroidism despite receiving a high dose of levothyroxine (L-T4) tablet as replacement therapy." | 4.12 | Switching from the tablet to the powder formulation of levothyroxine corrects severe hypothyroidism in a patient with lactose intolerance. ( Aso, Y; Iijima, T; Jojima, T; Kogai, T; Ohira, E; Sakurai, S; Shinzawa, T; Tomaru, T; Usui, I, 2022) |
| "Purpose: to determine lactose intolerance (LI) prevalence in women with Hashimoto’s thyroiditis (HT) and assess the impact of LI on LT4 replacement dose." | 4.12 | Prevalence of Lactose Intolerance in Patients with Hashimoto Thyroiditis and Impact on LT4 Replacement Dose. ( Albertelli, M; Bagnasco, M; Bodini, G; Ferone, D; Furnari, M; Giannini, EG; Giusti, M; Marabotto, E; Navarro Rojas, FA; Savarino, E; Savarino, V; Sheijani, AD; Vera, L; Zentilin, P; Ziola, S, 2022) |
| " However, an abnormality in the bioavailability of LT(4) should also be considered in patients requiring large doses of LT(4) to achieve euthyroidism." | 1.33 | Lactose intolerance revealed by severe resistance to treatment with levothyroxine. ( Alonso, G; Muñoz-Torres, M; Varsavsky, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jojima, T | 1 |
| Shinzawa, T | 1 |
| Ohira, E | 1 |
| Sakurai, S | 1 |
| Tomaru, T | 1 |
| Iijima, T | 1 |
| Kogai, T | 1 |
| Usui, I | 1 |
| Aso, Y | 1 |
| Marabotto, E | 1 |
| Ferone, D | 1 |
| Sheijani, AD | 1 |
| Vera, L | 1 |
| Ziola, S | 1 |
| Savarino, E | 1 |
| Bodini, G | 1 |
| Furnari, M | 1 |
| Zentilin, P | 1 |
| Savarino, V | 1 |
| Giusti, M | 1 |
| Navarro Rojas, FA | 1 |
| Bagnasco, M | 1 |
| Albertelli, M | 1 |
| Giannini, EG | 1 |
| Cellini, M | 1 |
| Santaguida, MG | 1 |
| Gatto, I | 1 |
| Virili, C | 1 |
| Del Duca, SC | 1 |
| Brusca, N | 1 |
| Capriello, S | 1 |
| Gargano, L | 1 |
| Centanni, M | 1 |
| Fallahi, P | 1 |
| Ferrari, SM | 1 |
| Marchi, S | 1 |
| De Bortoli, N | 1 |
| Ruffilli, I | 1 |
| Antonelli, A | 1 |
| Liwanpo, L | 1 |
| Hershman, JM | 1 |
| Fruzza, AG | 1 |
| Demeterco-Berggren, C | 1 |
| Jones, KL | 1 |
| Ruchała, M | 1 |
| Szczepanek-Parulska, E | 1 |
| Zybek, A | 1 |
| Muñoz-Torres, M | 1 |
| Varsavsky, M | 1 |
| Alonso, G | 1 |
2 reviews available for thyroxine and Alactasia
| Article | Year |
|---|---|
Conditions and drugs interfering with thyroxine absorption.
Topics: Aluminum Hydroxide; Animals; Antacids; Biological Availability; Calcium Carbonate; Celiac Disease; C | 2009 |
The influence of lactose intolerance and other gastro-intestinal tract disorders on L-thyroxine absorption.
Topics: Celiac Disease; Diet, Gluten-Free; Dose-Response Relationship, Drug; Drug Resistance; Gastrointestin | 2012 |
1 trial available for thyroxine and Alactasia
| Article | Year |
|---|---|
Systematic appraisal of lactose intolerance as cause of increased need for oral thyroxine.
Topics: Administration, Oral; Adolescent; Adult; Cohort Studies; Diet, Carbohydrate-Restricted; Dose-Respons | 2014 |
5 other studies available for thyroxine and Alactasia
| Article | Year |
|---|---|
Switching from the tablet to the powder formulation of levothyroxine corrects severe hypothyroidism in a patient with lactose intolerance.
Topics: Adult; Female; Humans; Hypothyroidism; Iodine Radioisotopes; Lactose Intolerance; Powders; Tablets; | 2022 |
Prevalence of Lactose Intolerance in Patients with Hashimoto Thyroiditis and Impact on LT4 Replacement Dose.
Topics: Adult; Aged; Female; Gastrointestinal Diseases; Hashimoto Disease; Humans; Lactose; Lactose Intolera | 2022 |
Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine.
Topics: Adult; Drug Compounding; Female; Hashimoto Disease; Hormone Replacement Therapy; Humans; Hypothyroid | 2017 |
Unawareness of the effects of soy intake on the management of congenital hypothyroidism.
Topics: Child, Preschool; Congenital Hypothyroidism; Female; Food-Drug Interactions; Humans; Infant, Newborn | 2012 |
Lactose intolerance revealed by severe resistance to treatment with levothyroxine.
Topics: Drug Resistance; Female; Humans; Hypothyroidism; Intestinal Absorption; Lactose Intolerance; Middle | 2006 |